13F

GOSS GOSSAMER BIO INC

2026Q1 · CUSIP 38341P102 · Sector: Healthcare & Biotech

Fading · Price holds, watch
Holders
183
Δ holders QoQ
-12
Breadth percentile
Top 88%
Whale holders
95
Δ whales
-4
Inst. holding value
$69M
New positions
46
Closed positions
58
Price momentum (1Q)
Put / Call
4/11

Breadth history (34 quarters)

2019Q2: Δ+3 · h=71 2019Q3: Δ+8 · h=79 2019Q4: Δ+9 · h=88 2020Q1: Δ+7 · h=95 2020Q2: Δ+15 · h=110 2020Q3: Δ+15 · h=125 2020Q4: Δ-2 · h=123 2021Q1: Δ+1 · h=124 2021Q2: Δ-8 · h=116 2021Q3: Δ+11 · h=127 2021Q4: Δ+5 · h=132 2022Q1: Δ+8 · h=140 2022Q2: Δ-11 · h=129 2022Q3: Δ+32 · h=161 2022Q4: Δ-40 · h=121 2023Q1: Δ-9 · h=112 2023Q2: Δ-12 · h=100 2023Q3: Δ-3 · h=97 2023Q4: Δ+2 · h=99 2024Q1: Δ+11 · h=110 2024Q2: Δ-15 · h=95 2024Q3: Δ+6 · h=101 2024Q4: Δ+5 · h=106 2025Q1: Δ+15 · h=121 2025Q2: Δ+4 · h=125 2025Q3: Δ+39 · h=164 2025Q4: Δ+31 · h=195 2026Q1: Δ-12 · h=183 2019Q2: holders=71 2019Q3: holders=79 2019Q4: holders=88 2020Q1: holders=95 2020Q2: holders=110 2020Q3: holders=125 2020Q4: holders=123 2021Q1: holders=124 2021Q2: holders=116 2021Q3: holders=127 2021Q4: holders=132 2022Q1: holders=140 2022Q2: holders=129 2022Q3: holders=161 2022Q4: holders=121 2023Q1: holders=112 2023Q2: holders=100 2023Q3: holders=97 2023Q4: holders=99 2024Q1: holders=110 2024Q2: holders=95 2024Q3: holders=101 2024Q4: holders=106 2025Q1: holders=121 2025Q2: holders=125 2025Q3: holders=164 2025Q4: holders=195 2026Q1: holders=183 -40 -20 +0 +20 +40 63134205 19Q220Q120Q421Q322Q223Q123Q424Q325Q226Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 7 lit events

Period Percentile Next-1Q return Next-2Q return
2025Q4 Top 17% -91.0%
2025Q3 Top 7% -29.4% -92.8%
2025Q1 Top 16% +76.1% +174.3%
2022Q3 Top 2% -76.1% -83.4%
2021Q3 Top 17% -23.5% -34.2%
2020Q3 Top 17% +14.9% -0.9%
2020Q1 Top 12% -5.5% -39.1%

Options Sentiment

Put holders
4
QoQ: -6
Call holders
11
QoQ: -2

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-0.79
EPS YoY
Revenue (TTM)
$0.1B
Revenue YoY
-55.4%
Quarterly Revenue & EPS (4Y)
2023-06-30: $0M 2023-09-30: $0M 2024-03-31: $0M 2024-06-30: $96M 2024-09-30: $9M 2024-12-31: $9M 2025-03-31: $10M 2025-06-30: $11M 2025-09-30: $13M 2025-12-31: $14M 2026-03-31: $17M 2023-09-30: EPS -0.21 2023-12-31: EPS 0.00 2024-03-31: EPS -0.19 2024-06-30: EPS 0.22 2024-09-30: EPS -0.14 2024-12-31: EPS -0.14 2025-03-31: EPS -0.16 2025-06-30: EPS -0.17 2025-09-30: EPS -0.21 2025-12-31: EPS -0.21 2026-03-31: EPS -0.20 0M 48M 96M $M -0.23 0.01 0.24 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)